Park Avenue Securities’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Other funds holding GMED
JT
SC
Park Avenue Securities's GMED Position: Q2 2026 in Review
Park Avenue Securities increased its Globus Medical (GMED) stake by 179% in Q2 2026, buying an estimated $940K and bringing the position to 17,245 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #824.
Park Avenue Securities first reported a position in GMED in Q4 2020 and has held it in 20 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Park Avenue Securities held 17,245 shares of Globus Medical worth $1.36M as of Q2 2026.
- Park Avenue Securities bought 11,057 Globus Medical shares in Q2 2026, an estimated $940K.
- Globus Medical made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #824 holding.
- Park Avenue Securities first reported a position in Globus Medical in Q4 2020 and has held it in 20 quarters since.
- 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.